SPY320.06+8.70 2.79%
DIA272.11+8.78 3.33%
IXIC9,832.93+217.12 2.26%

Kala Pharmaceuticals Q1 EPS $(0.540) Misses $(0.510) Estimate

Kala Pharmaceuticals (NASDAQ:KALA) reported quarterly losses of $(0.540) per share which missed the analyst consensus estimate of $(0.510) by 5.88 percent. This is a 28 percent increase over losses of $(0.750) per share

Benzinga · 05/07/2020 11:14

Kala Pharmaceuticals (NASDAQ:KALA) reported quarterly losses of $(0.540) per share which missed the analyst consensus estimate of $(0.510) by 5.88 percent. This is a 28 percent increase over losses of $(0.750) per share from the same period last year.